logo
Log inSign up
logo

Merck Delaware Plant Investment

Sector: Commercial • Location: Delaware, United States

Source: Business Recorder

Project
Planned

Merck is investing $1 billion in a new plant in Delaware to expand domestic production of biologic drugs, including Keytruda, its cancer treatment. This facility will be the first in-house U.S. site for Keytruda production and is expected to create at least 500 full-time jobs and 4,000 construction vacancies.

Status
Prospective
Sector
Commercial
Location
Delaware, United States of America
Updated
22 Jul 2026
Source
Business Recorder

ConstructChat

Ask ConstructChat about Merck Delaware Plant Investment

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Merck Delaware Plant Investment” is an infrastructure initiative in the Commercial sector, located in Delaware, United States. Taiyo aggregates data on it from Business Recorder.

Participants

Not available for this record.

Status

Original status

Planned

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Merck is investing $1 billion in a new plant in Delaware to expand domestic production of biologic drugs, including Keytruda, its cancer treatment. This facility will be the first in-house U.S. site for Keytruda production and is expected to create at least 500 full-time jobs and 4,000 construction vacancies.

Budget

Location

Country

United States of America (USA)

State

Delaware

Source

Source

Business Recorder

URL

More Details

Record type

Project

Sector

Commercial

Article published date

2025-05-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project